These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31452588)

  • 21. Comparison of Outcomes of Coronary Artery Bypass Grafting Using Internal Mammary Graft Versus Percutaneous Coronary Intervention for Isolated Proximal Left Anterior Descending Narrowing.
    Iqbal MB; Ilsley C; De Robertis F; Lane R; Kabir T; Bahrami T; Simon A; Popov A; Amrani M; Dalby MC; Mason M; Grocott-Mason R; Smith RD; Raja SG
    Am J Cardiol; 2017 Mar; 119(5):719-726. PubMed ID: 28038726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of repeated stent fracture.
    Migita S; Murata N; Takahashi K; Nakajima Y; Mizobuchi S; Miyagawa M; Tanaka Y; Fukumoto K; Arai R; Morikawa T; Mineki T; Kojima K; Sudo M; Fukamachi D; Okumura Y
    Oxf Med Case Reports; 2024 Jul; 2024(7):omae075. PubMed ID: 39040533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dislodgement of a sirolimus-eluting stent in the circumflex artery and its successful deployment with a small-balloon technique.
    Sentürk T; Ozdemir B; Yeşilbursa D; Serdar OA
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):418-21. PubMed ID: 21743268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis.
    Sillano D; Moretti C; Biondi-Zoccai G; Sheiban I
    Minerva Cardioangiol; 2008 Feb; 56(1):167-70. PubMed ID: 18432178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent Deformation Caused by Entrapment of the Side Branch Balloon Catheter During the Jailed Balloon Protection Technique for a Calcified Coronary Bifurcation Lesion: A Case Report and Literature Review.
    Numasawa Y; Hitomi Y; Imaeda S; Yokokura S; Tanaka M; Tabei R; Kodaira M
    Cardiovasc Revasc Med; 2019 Nov; 20(11):1023-1026. PubMed ID: 30497930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of coronary lesion with lotus root appearance treated by percutaneous coronary intervention with intravascular ultrasound guidance.
    Nakanishi T; Kawata M; Matsuura T; Kuroda M; Mori K; Hirayama Y; Adachi K; Matsuura A; Sakamoto S
    Cardiovasc Interv Ther; 2010 Jul; 25(2):131-4. PubMed ID: 24122475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stent malapposition occurred 17 days following percutaneous coronary intervention for a severe calcified lesion in acute myocardial infarction.
    Takano T; Ozaki K; Hoyano M; Yanagawa T; Ozawa T; Minamino T
    J Cardiol Cases; 2019 Jul; 20(1):4-7. PubMed ID: 31320944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worsening late-acquired incomplete stent apposition after sirolimus-eluting stent implantation for a chronic total occlusion lesion.
    Nakazato K; Misaka T; Sakamoto N; Kunii H; Saitoh S; Takeishi Y
    Cardiovasc Interv Ther; 2015 Jan; 30(1):85-91. PubMed ID: 24595874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different expansion strategies on coronary stent deployment in a tapered artery.
    Shen X; Ji S; Xie Z; Deng Y
    Technol Health Care; 2017 Jul; 25(S1):21-28. PubMed ID: 28582888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
    Bangalore S; Toklu B; Feit F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India.
    Chandwani P; Prajapati J; Porwal S; Khambhati B; Thakkar A
    J Clin Diagn Res; 2015 Feb; 9(2):OC05-9. PubMed ID: 25859478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter.
    Price MJ; Saito S; Shlofmitz RA; Spriggs DJ; Attubato M; McLaurin B; Popma Almonacid A; Brar S; Liu M; Moe E; Mehran R
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1381-1388. PubMed ID: 28728650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.